EUVIMEDEUVIMED entdecken
Open Access

Outcomes associated with initial narrow‐spectrum versus broad‐spectrum antibiotics in children hospitalized with urinary tract infections

Jessica L Markham iD, Alaina Burns, Matthew Hall iD, Matthew J Molloy iD, John R Stephens iD, Elisha McCoy, Irma T Ugalde iD, Michael J Steiner, Jillian M Cotter iD, Samantha A House iD, Megan E Collins iD, Andrew G Yu und 2 weitere

Journal of Hospital Medicine · 2024

DOI: 10.1002/jhm.13390 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hospital Medicine, 2024. Verfasst von Jessica L Markham und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Children's Mercy Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA. Hauptthemen laut MEDLINE: Urinary Tract Infections, Anti-Bacterial Agents, Length of Stay. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, PEDSnet Scholars Training Program, AHRQ HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim of this study is to describe the proportion of children hospitalized with urinary tract infections (UTIs) who receive initial narrow‐ versus broad‐spectrum antibiotics across children's hospitals and explore whether the use of initial narrow‐spectrum antibiotics is associated with different outcomes. Design, Setting and Participants We performed a retrospective cohort analysis of children aged 2 months to 17 years hospitalized with UTI (inclusive of pyelonephritis) using the Pediatric Health Information System (PHIS) database. Main Outcome and Measures We analyzed the proportions of children initially receiving narrow‐ versus broad‐spectrum antibiotics; additionally, we compiled antibiogram data for common uropathogenic organisms from participating hospitals to compare with the observed antibiotic susceptibility patterns. We examined the association of antibiotic type with adjusted outcomes including length of stay (LOS), costs, and 7‐ and 30‐day emergency department (ED) revisits and hospital readmissions.

Results

We identified 10,740 hospitalizations for UTI across 39 hospitals. Approximately 5% of encounters demonstrated initial narrow‐spectrum antibiotics, with hospital‐level narrow‐spectrum use ranging from 80% Escherichia coli susceptibility to cefazolin. In adjusted models, those who received initial narrow‐spectrum antibiotics had shorter LOS (narrow‐spectrum: 33.1 [95% confidence interval; CI]: 30.8–35.4] h vs. broad‐spectrum: 46.1 [95% CI: 44.1–48.2] h) and reduced costs (narrow‐spectrum: $4570 [$3751–5568] versus broad‐spectrum: $5699 [$5005–$6491]). There were no differences in ED revisits or hospital readmissions. In summary, children's hospitals have low rates of narrow‐spectrum antibiotic use for UTIs despite many reporting high rates of cefazolin‐susceptible E. coli . These findings, coupled with the observed decreased LOS and costs among those receiving narrow‐spectrum antibiotics, highlight potential antibiotic stewardship opportunities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Tract InfectionsAnti-Bacterial AgentsLength of StayHumansRetrospective StudiesChildChild, PreschoolFemaleInfantMaleAdolescentHospitalizationHospitals, PediatricMicrobial Sensitivity TestsPatient Readmission

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pediatrics, Children's Mercy Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.
  • Department of Pediatrics, University of Kansas School of Medicine, Kansas City, Kansas, USA.
  • Department of Pharmacy, Children's Mercy Kansas City, University of Missouri-Kansas City School of Pharmacy, Kansas City, Missouri, USA.
  • Children's Hospital Association, Lenexa, Kansas, USA.
  • Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

ORCID-Profile: Jessica L Markham, Matthew Hall, Matthew J Molloy, John R Stephens, Irma T Ugalde, Jillian M Cotter, Samantha A House, Megan E Collins, Michael J Tchou, Samir S Shah

Förderung

  • NCATS NIH HHS
  • PEDSnet Scholars Training Program
  • AHRQ HHS
  • Agency for Healthcare Research and Quality

Zitieren

APA

Markham, J. L., Burns, A., Hall, M., Molloy, M. J., Stephens, J. R., McCoy, E., Ugalde, I. T., Steiner, M. J., Cotter, J. M., House, S. A., Collins, M. E., Yu, A. G., Tchou, M. J., & Shah, S. S. (2024). Outcomes associated with initial narrow‐spectrum versus broad‐spectrum antibiotics in children hospitalized with urinary tract infections. Journal of Hospital Medicine. https://doi.org/10.1002/jhm.13390

Vancouver

Markham JL, Burns A, Hall M, Molloy MJ, Stephens JR, McCoy E, et al. Outcomes associated with initial narrow‐spectrum versus broad‐spectrum antibiotics in children hospitalized with urinary tract infections. Journal of Hospital Medicine. 2024. doi:10.1002/jhm.13390

BibTeX
@article{Markham2024,
  author = {Markham, Jessica L and Burns, Alaina and Hall, Matthew and Molloy, Matthew J and Stephens, John R and McCoy, Elisha and Ugalde, Irma T and Steiner, Michael J and Cotter, Jillian M and House, Samantha A and Collins, Megan E and Yu, Andrew G and Tchou, Michael J and Shah, Samir S},
  title = {Outcomes associated with initial narrow‐spectrum versus broad‐spectrum antibiotics in children hospitalized with urinary tract infections},
  journal = {Journal of Hospital Medicine},
  year = {2024},
  doi = {10.1002/jhm.13390}
}
Kostenlos starten →